Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).

Publikation

Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).

Wissenschaftlicher Artikel/Review - 26.01.2023

Achtnichts Lutz, Zecca Chiara, Findling Oliver, Kamm Christian Philipp, Müller Stefanie, Kuhle Jens, Lutterotti Andreas, Gobbi Claudio, Viviani Camille, Villiger-Borter Emanuela, Nedeltchev Krassen

Achtnichts, Lutz

Zecca, Chiara

Findling, Oliver

Kamm, Christian Philipp

Müller, Stefanie

Neurologie · Dept. III

Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).

Achtnichts, Lutz

Zecca, Chiara

Findling, Oliver

Kamm, Christian Philipp

Müller, Stefanie

Kuhle, Jens

Lutterotti, Andreas

Gobbi, Claudio

Viviani, Camille

Villiger-Borter, Emanuela

Nedeltchev, Krassen